A new eye drop therapy offers a non-invasive alternative for treating dry age-related macular degeneration. Massively ...

Toll-like receptors (TLRs) are vital components of the immune system, acting as sentinels that detect and respond to ...

New treatments for macular degeneration may help preserve your eyesight for longer, without the need for frequent injections. Some of these treatments include retinal gene therapy and the "port" ...

The FDA has approved a first-of-its-kind treatment for dry age-related macular degeneration (AMD), a leading cause of blindness in adults over 55.

Jedd Comiskey, Senior Vice President, Head of Europe, highlights the recent NICE recommendation of LYTENAVA™ (bevacizumab gamma) for the treatment of wet AMD Access the segment here ISELIN, N.J., Jan.

Since July 2024, faricimab has also been approved in Europe for the treatment of visual impairment due to macular edema ...

It can be a shock to learn that you have a serious medical problem like wet age-related macular degeneration. Realistically, the condition is likely to disrupt your everyday life, at least for a while ...

A recent study found that the triple-layer sign (TLS) obtained on optical coherence tomography has high sensitivity and ...

This article discusses some of the new treatments that are emerging to treat both wet and dry age-related macular degeneration (AMD). Related: Wet vs. Dry Age-Related Macular Degeneration New ...

Shares of Outlook Therapeutics jumped after the company said it continues to progress the development of its treatment for wet age-related macular degeneration, which causes blurred or reduced central ...

Pravin U. Dugel, MD, Ocular's Executive Chairman, President and CEO, will provide an update regarding the enrollment status ...